Regulations.gov document
Identification, Assessment, and Control of Nitrosamine Drug Substance-Related Impurities…
Notice · FDA-2023-N-1585 · posted May 4, 2023
Key facts
| Document ID | FDA-2023-N-1585-0001 |
|---|---|
| Title | Identification, Assessment, and Control of Nitrosamine Drug Substance-Related Impurities in Human Drug Products; Establishment of a Public Docket; Request for Comments |
| Document type | Notice |
| Subtype | Request for Comments |
| Agency | FDA |
| Docket | FDA-2023-N-1585 |
| Posted | May 4, 2023 |
| Federal Register citation | 88 FR 28557 |
| FR document number | 2023-09526 |
| Comment period opens | May 4, 2023 |
| Comments due | Jul 4, 2023 |
| Effective date | May 4, 2023 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: